Search

The anisotropic optical properties of single crystal SrLaAlO4 are investigated using spectroscopic ellipsometry over the range from 0.74 to 5.90 eV. Divided spectral range analysis of ellipsometric and Mueller matrix spectra are used to obtain the sample structural parameters (surface roughness thickness and void fraction). The ordinary and extra-ordinary optical properties in the form of complex dielectric function, ϵ = ϵ1 + iϵ2 (or complex index of refraction, N = n + ik), spectra are extracted from the same analysis. The observed birefringence is ∼ 0.025 in the transparent range. An upper limit for the indirect gap at 3.01 ± 0.01 eV and a critical point at 5.54 ± 0.01 eV are identified within the measured spectral range.

High efficiency, broad bandwidth, and robust angular tolerance are key considerations in photonic device design. Here, a few-layer, asymmetric light transmitting metasurface that simultaneously satisfies all the above requirements is reported. The metasurface consists of coupled metallic sheets. It has a measured transmission efficiency of 80%, extinction ratio of 13.8 dB around 1.5 μm, and a full width half maximum bandwidth of 1.7 μm. It is as thin as 290 nm, has good performance tolerance against the angle of incidence and constituent nano-structure geometry variations. This work demonstrates a practical asymmetric light transmission device with optimal performance for large scale manufacturing.

Gastroesophageal reflux disease is the most common upper gastroenterology disorder in the US. It is associated with a variety of complications and significantly impacts quality of life. Proton pump inhibitors are the most effective treatment. Dexlansoprazole modified release (MR) is a proton pump inhibitor that employs a novel release formulation that prolongs its absorption and allows for more flexibility in dosing. Dexlansoprazole MR can be dosed without regard to food intake or time of day, and once-daily dosing may replace twice-daily dosing of other agents. Dexlansoprazole MR is effective for healing and maintenance of erosive esophagitis, and for the treatment of nonerosive disease, including nocturnal gastroesophageal reflux disease. Dexlansoprazole MR is safe and well tolerated, and can improve quality of life.

Noise is a global occupational and environmental health hazard with considerable social and physiological impact and, therefore, there is a need for regular measurements to boost monitoring and regulations of environmental noise levels in our communities. This necessitates a readily available, inexpensive, and easy to use noise measuring device. We aimed to test the sensitivity and validity of mobile "smart" phones for this purpose. This was a comparative analysis of a cross sectional study done between January 2014 and February 2015. Noise levels were measured simultaneously at different locations within Abuja Nigeria at day and night hours in real time environments. A sound level meter (SLM) (Extech407730 Digital Soundmeter, serial no.: 2310135, calibration no: 91037) and three smartphones (Samsung Galaxy note3, Nokia S, and Techno Phantom Z running on Android "Apps" Androidboy1) were used. Statistical calculations were done with Pearson correlation, T-test and Consistency within American National Standards Institute acceptable standard errors. Noise level readings for both daytime and night with the SLM and the mobile phones showed equivalent values. All noise level meters measured were

Background: Ebola virus disease (EVD) is a viral hemorrhagic illness with great propensity for spread across international borders. The latest outbreak in the West African region, which involved Nigeria, was the worst among previously documented 25 outbreaks since discovery in 1976. The Nigerian response toward attaining Ebola free status was phenomenal and a case study for most nations. However, the persistence of EVD in West Africa is still a risk to recurrence, hence, the need to assess the level of consciousness of Nigerian physicians towards this. Methodology: A cross-sectional study utilizing the instrument of a pretested semi-structured questionnaire was conducted among physicians practicing within the federal capital city of Nigeria. General knowledge, treatment, prevention, and reporting of EVD were assessed and appropriate statistical analyses done using SPSS 20. Results: Of the 101 respondents, 45% and 87% showed excellent level (>80% score) of “general knowledge” and “reporting” on EVD, respectively. However, only 51% respondents had good (60–80%) knowledge on EVD treatment. Three percent correctly identified the “EVD helpline” phone-numbers for reporting suspected cases. Furthermore, 43.6% admitted the availability of personal protective equipment (PPE) in their hospitals while 35.6% had witnessed a demonstration of the use. The distribution of the PPEs appeared skewed - 74.4% (teaching-hospitals), 16% (private-hospitals), and the primary health care centers (9.6%). Conclusion: A majority of the physicians showed good level of preparedness as it relates to general knowledge on EVD, knowledge on good clinical practice, use of protocols and standard precautions and PPE. The identification of deficits in knowledge on treatment of EVD and flow path for the notification of suspected cases requires urgent redress given the risk of re-occurrence in the country.

Reluctantly leaving an end-of-life house call with a patient who has decided to avail himself of his state’s death-with-dignity law, a physician hears a musical composition that reframes the experience in terms of the dialectic of Man versus Nature.

Purpose: Treatment of patients with relapsed or refractory lymphoid neoplasms represents a significant clinical challenge, largely due to the genetic heterogeneity of these malignancies. Our study goal was to design a rational treatment strategy that simultaneously targets multiple disease drivers to provide safe, efficacious, and durable responses in patients with relapsed or refractory non-Hodgkin lymphoma (NHL). Experimental procedures and data summary: Venetoclax is a selective BCL-2 inhibitor that induces apoptosis and is efficacious in chronic lymphocytic leukemia; however, single-agent efficacy in other lymphoid neoplasms is limited. Using pharmacologic and genetic studies, we identified the pro-survival BCL-2 protein family member MCL-1 as a venetoclax resistance factor in NHL cell lines. We found that the monomethyl auristatin E (MMAE) payload of the antibody-drug conjugate polatuzumab vedotin promotes MCL-1 degradation via the ubiquitin/proteasome system, thus providing a strong rationale for combination with venetoclax. Mechanistically, polatuzumab vedotin combined with venetoclax promoted apoptotic NHL cell death. In NHL animal models, venetoclax, polatuzumab vedotin, and the anti-CD20 antibody obinutuzumab, that activates targeted antibody- and complement-dependent cell cytotoxicity, produced durable tumor regressions. In a phase 1b clinical trial, 33 patients with relapsed or refractory follicular lymphoma were evaluable for response over 6 dose levels with 19 complete responses and 6 partial responses (overall response rate 76%). All patients (8 of 8) treated with the recommended phase 2 regimen (venetoclax 800mg + polatuzumab vedotin 1.8mg/kg + obinutuzumab 1000mg) achieved complete responses at end of induction. The median duration of follow-up for all dose levels was 17.7 months. This triplet combination was well-tolerated by most patients and had an expected and acceptable safety profile. Conclusions: Our studies implicate MCL-1 as a key venetoclax resistance factor in NHL that can be overcome by polatuzumab vedotin, which promotes MCL-1 degradation. Pre-clinical NHL animal models and early clinical data confirmed that the combination of venetoclax, polatuzumab vedotin, and obinutuzumab is safe and promotes durable responses. Because MMAE and other anti-tubulin agents are likely not the only therapeutics that antagonize MCL-1, our study provides scientific rationale to pursue the broader strategy of identifying other therapeutics that similarly neutralize MCL-1 function. Such agents could be used in combination with venetoclax in other malignancies where MCL-1 is a venetoclax resistance factor. Our mechanism-based treatment regimen that directly targets oncogenic drivers in NHL patients may serve as a framework for treating other malignancies with complex etiologies. Citation Format: Dhara N. Amin, Rajat Bannerji, Raghuveer Singh Mali, Jason Oeh, Eva Lin, Anuradha Zindal, MaryAnn Go, Shang-Fan Yu, Maxwell Krem, Chris Arthur, Uwe Hahn, Anna M. Johnston, Vinit G. Karur, Nadia Khan, Paula Marlton, Tycel Phillips, Giuseppe Gritti, John F. Seymour, Monica Tani, Sam Yuen Yuen, Scott Martin, Matthew T. Chang, Christopher M. Rose, Victoria C. Pham, Elizabeth A. Lasater, Andrew G. Polson, YiMeng Chang, Jamie Hirata, Lisa Musick, Deepak Sampath, Christopher R. Flowers, Ingrid E. Wertz. Targeting BCL-2 and MCL-1 overcomes treatment resistance in relapsed and refractory non-Hodgkin lymphoma: Pre-clinical rationale and results from an open-label phase 1b study [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr CT133.

Narrow bandgap mixed tin (Sn) + lead (Pb) perovskites are necessary for the bottom sub-cell absorber in high efficiency all-perovskite polycrystalline tandem solar cells. We report on the impact of mixed cation composition and atmospheric exposure of perovskite films on sub-gap absorption in films and performance of solar cells based on narrow bandgap mixed formamidinium (FA) + methylammonium (MA) and Sn + Pb halide perovskites, (FASnI3)x(MAPbI3)1-x. Structural and optical properties of 0.3 ≤ x ≤ 0.8 (FASnI3)x(MAPbI3)1-x perovskite thin film absorbers with bandgaps ranging from 1.25 eV (x = 0.6) to 1.34 eV (x = 0.3) are probed with and without atmospheric exposure. Urbach energy, which quantifies the amount of sub-gap absorption, is tracked for pristine perovskite films as a function of composition, with x = 0.6 and 0.3 demonstrating the lowest and highest Urbach energies of 23 meV and 36 meV, respectively. Films with x = 0.5 and 0.6 compositions show less degradation upon atmospheric exposure than higher or lower Sn-content films having greater sub-gap absorption. The corresponding solar cells based on the x = 0.6 absorber show the highest device performance. Despite having a low Urbach energy, higher Sn-content solar cells show reduced device performances as the amount of degradation via oxidation is the most substantial.

Cadmium telluride (CdTe) thin films with different microstructures and optical properties have been produced on soda-lime glass by glancing angle deposition (GLAD) at oblique sputtering angles varying from 0° to 80° with respect to the substrate normal. From cross-sectional scanning electron micrographs, increasingly tilted columnar structure occurs with increasing incident angle for as-deposited CdTe films. CdTe films deposited at lower angles closer to normal incidence consist of a mixture of cubic zinc blende and hexagonal wurtzite crystal structures while films prepared at more oblique angles have hexagonal wurtzite crystal structure. Post-deposition CdCl2 treated films show enhancement in crystallite/grain size for samples prepared under all conditions. The optical response in the form of the complex dielectric function (e = e1 + ie2) spectra from 0.74 to 5.89 eV for the GLAD thin films are all qualitatively similar to single crystal CdTe. Higher angle deposited samples show columnar structure induced anisotropy in spectra in e in the transparent spectral range. Application of GLAD CdTe interlayers between CdS and CdTe of the standard CdS/CdTe heterojunction design solar cell shows better performance with up to 0.9% absolute efficiency increase.

Gastroesophageal reflux disease (GERD) is the most common upper gastrointestinal disorder in the United States. Although proton pump inhibitors (PPIs) are the mainstay of therapy for GERD and its complications, they have several limitations, including incomplete symptom resolution. Potassium-competitive acid blockers (P-CABs) were developed to address the limitations of PPIs as well as the need for improved antisecretory effects. Tegoprazan, the newest P-CAB, was approved in 2018 in South Korea for the treatment of erosive esophagitis (EE) and nonerosive reflux disease (NERD). A highly selective inhibitor of the H+/K+-ATPase, tegoprazan is also safe and effective for nocturnal acid breakthrough (NAB) and motility. Further studies of tegoprazan are warranted to define its potential role in the treatment of acid-related disorders.

High-dose busulfan (BU) followed by high-dose cyclophosphamide (CY) before allogeneic hematopoietic cell transplantation (HCT) has long been used as treatment for hematologic malignancies. Administration of phenytoin or newer alternative antiepileptic medications (AEMs) prevents seizures caused by BU. Phenytoin induces enzymes that increase exposure to active CY metabolites in vivo, whereas alternative AEMs do not have this effect. Lower exposure to active CY metabolites with the use of alternative AEMs could decrease the risk of toxicity but might increase the risk of recurrent malignancy after HCT. Previous studies have not determined whether outcomes with alternative AEMs differ from those with phenytoin in patients treated with BU/CY before allogeneic HCT. We studied a cohort of 2155 patients, including 1460 treated with phenytoin and 695 treated with alternative AEMs, who received BU/CY before allogeneic HCT between 2004 and 2014. We found no differences suggesting decreased overall survival or relapse-free survival or increased risks of relapse, nonrelapse mortality, acute or chronic graft-versus-host disease, or regimen-related toxicity associated with the use of alternative AEMs compared with phenytoin. The risk of dialysis was lower in the alternative AEM group than in the phenytoin group. Alternative AEMs are safe for prevention of seizures after BU administration and can avoid the undesirable toxicities and drug interactions caused by phenytoin.

© 2018. The American Astronomical Society. All rights reserved.. This paper describes the second data release (DR2) of the Beijing-Arizona Sky Survey (BASS). BASS is an imaging survey covering a 5400 deg2 footprint in the g and r bands using the 2.3 m Bok telescope. DR2 includes the observations through 2017 July obtained by BASS and by the Mayall z-band Legacy Survey (MzLS), which used the 4 m Mayall telescope to observe the same footprint. BASS and MzLS have completed 72% and 76% of their observations. The two surveys will be served for the spectroscopic targeting of the upcoming Dark Energy Spectroscopic Instrument. Both BASS and MzLS data are reduced by the same pipeline. We have updated the basic data reduction and photometric calibrations in DR2. In particular, source detections are performed on stacked images, and photometric measurements are co-added from single-epoch images based on these sources. The median 5σ point-source depths after Galactic extinction corrections are 24.05, 23.61, and 23.10 mag for the g, r, and z bands, respectively. The DR2 data products include stacked images, co-added catalogs, and single-epoch images and catalogs. The BASS website (http://batc.bao.ac.cn/BASS/) provides detailed information and links to download the data.

A parametric optical model is developed for use in analyzing spectroscopic ellipsometry (SE) measurements of CdTe and $CdSe_{1-y}Te_{y}$ alloy films. Through fitting to measurements of a series of CdCl2 treated alloys spanning the full range of compositions, a database describing the optical response of $CdSe_{1-y}Te_{y}$ as a function of y is compiled. More specifically, spectral features are mathematically related to y, including bandgap-bowing. Additionally, the parametric model has the capability of quantitatively describing defect-induced sub-bandgap absorption through the determination of an Urbach energy (Eu). The accuracy of the SE-determined Eu is verified through complementary photothermal deflection spectroscopy measurements. For instance, Eu describing a CdTe film is measured to decrease from 42 to 20 meV after undergoing CdCl2 treatment. External quantum efficiency simulations of full solar cell structures making use of this database can be compared to actual measurements of devices to identify the source of performance gains and or losses as well as the composition of alloyed material within such devices.

Optical characterization and simulations have been applied to study formamidinium + cesium lead triiodide (FA}1}$X \mathbf{Cs} X$textbf{PbI3}\textbf{) perovskite thin films and solar cells. Near infrared to ultraviolet complex index of refraction ($N = n +_{\mathbf{\, }} ik$) spectra of varying cesium-to-formamidinium ratios in solution processed perovskite thin films have been extracted. Critical point transitions and the absorption onset are extracted, with $x =$ 0.2 showing the sharpest absorption edge and least contribution from defects to absorption near the band edge. External quantum efficiency simulations of perovskite based solar cells using optical properties as input are performed and compared to experimental device results.

Optical and microstructural properties of as-deposited CdTe films deposited on soda lime glass by magnetron sputtering at various source flux angles have been investigated using GIXRD, SEM, unpolarized transmittance / reflectance, and spectroscopic ellipsometry. Influence of deposition angle on resultant crystalline grain size and orientation are tracked for these films. All CdTe films studied are found to have cubic crystal structure and (111) preferential grain orientation. Films deposited at $0 ^{circ}$ and $45 ^{circ}$ are almost entirely (111) oriented, whereas films deposited at higher angles exhibit a wider variety of competing grain orientations, suggesting that deposition angle can be used as an effective parameter towards controlling grain orientation. With increasing numbers of grain orientations, grain size is found to decrease. Ex-situ spectroscopic ellipsometry is used to obtain the structural and optical properties. Stress induced in the film is calculated based on shifts of critical point energies.

Spectroscopic ellipsometry (SE) was performed on CuIn Se 2 (CIS) thin films and solar cells with a goal toward optimizing this low bandgap absorber for tandem applications. The CIS thin films and the absorbers in devices were deposited by one-stage thermal co-evaporation on silicon and on Mo-coated soda-lime glass substrates in a deposition system that has yielded CuIn 1-x Ga x Se 2 (CIGS) cells with > 17% efficiency using standard thickness (2.0 μm)x = 0.3 absorbers and > 13% using 0.7 μm low-Ga absorbers. In this study, a mapping capability for CIS Cu stoichiometry y = [Cu]/[In] over the film area was established based on a y-dependent parametric dielectric function (e 1 , e 2 ) with bandgap critical point E g decreasing linearly from 1.030 eV for y = 0.7 to 1.016 eV for y = 1.1. In addition, a full set of (e 1 , e 2 ) spectra measured for the CIS cell components enables analysis of SE data in terms of an accurate structural model for the device. With this model, spectra in the external quantum efficiency can be predicted, and deviations from this prediction can be attributed to incomplete collection of photogenerated electrons and holes as simulated with a carrier collection profile.

Across species, cooperative alliances must withstand internal tensions. The mechanisms by which allies respond to competing against one another have been studied extensively in non-human animals, but much less so in humans. In non-human species, affiliative physical contact and close proximity immediately following a contest are utilized to define reconciliation between opponents. The proportion of conflicts that are reconciled however differs markedly by species and sex. The purpose of this study was to examine whether, like many other social species, humans utilize physical contact and close proximity following a competition between friends, and if so, whether one sex is more likely to exhibit these behaviors. Using a standardized procedure, two same-gender friends competed against one another producing a clear winner and loser. Prior to and following the competition, the friends relaxed together. Videotapes of the relaxation periods showed that male friends spent more time than female friends engaged in affiliative physical contact and close proximity both before and after the competition, but not during a brief intervening cooperative task. These results suggest that in the face of competing self-interests, physical contact and close proximity facilitate repair of males’ more than females’ valuable relationships.

Significant advances in our understanding of normal development and disease have been facilitated by engineered mice in which genes can be altered in a spatially, temporally, or cell type restricted manner using site specific recombinase systems like Cre-loxP or Flp-frt. In many circumstances it is important to understand how interactions between multiple genes influence a given phenotype. Robust approaches for precisely controlling multiple genetic alterations independently are limited, however, thus the impact of mutation order and timing on phenotype is generally unknown. Here we describe and validate a novel Gt(ROSA)26Sor targeted transgene allowing precise control over the order and timing of multiple genetic mutations in the mouse. The transgene expresses an optimized, Flp-estrogen receptor fusion protein (Flpo-ERT2) under the control of a loxP-stop-loxP cassette. In this system, genes modified by loxP sites are altered first upon expression of Cre. Cre also eliminates the loxP-stop-loxP cassette, permitting wide-spread expression of Flpo-ERT2. Because of the estrogen receptor fusion, Flp activity remains inert until administration of tamoxifen, allowing genes modified by frt sites to be modified subsequently with controllable timing. This mouse transgene will be useful in a wide variety of applications where independent control of different mutations in the mouse is desirable.

To review systematically the published literature regarding the impact of treatment for OSA on monetized health economic outcomes.Customized structured searches were performed in PubMed, Embase (Embase.com), and the Cochrane Central Register of Controlled Trials (Wiley) databases. Reference lists of eligible studies were also analyzed. Titles and abstracts were examined, and articles were identified for full-text review. Studies that met inclusion criteria were evaluated in detail, and study characteristics were extracted using a standardized template. Quantitative characteristics of the studies were summarized, and a qualitative synthesis was performed.Literature searches identified 2,017 nonredundant abstracts, and 196 full-text articles were selected for review. Seventeen studies met inclusion criteria and were included in the final synthesis. Seven studies included formal cost-effectiveness or cost-utility analyses. Ten studies employed cohort designs, and four studies employed randomized controlled trial or quasi-experimental designs. Positive airway pressure was the most common treatment modality, but oral appliances and surgical approaches were also included. The most common health economic outcomes were health-care use (HCU) and quality-adjusted life years (QALYs). Follow-ups ranged from 6 weeks to 5 years. Overall, 15 of 18 comparisons found that treatment of OSA resulted in a positive economic impact. Treatment adherence and OSA severity were positively associated with cost-effectiveness.Although study methodologies varied widely, evidence consistently suggested that treatment of OSA was associated with favorable economic outcomes, including QALYs, within accepted ranges of cost-effectiveness, reduced HCU, and reduced monetized costs.

Joseph Mermelstein,1 Alanna Chait Mermelstein,2 Maxwell M Chait3 1Gasteroenterology and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; 2Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA; 3Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA Abstract: A significant percentage of patients with gastroesophageal reflux disease (GERD) will not respond to proton pump inhibitor (PPI) therapy. The causes of PPI-refractory GERD are numerous and diverse, and include adherence, persistent acid, functional disorders, nonacid reflux, and PPI bioavailability. The evaluation should start with a symptom assessment and may progress to imaging, endoscopy, and monitoring of esophageal pH, impedance, and bilirubin. There are a variety of pharmacologic and procedural interventions that should be selected based on the underlying mechanism of PPI failure. Pharmacologic treatments can include antacids, prokinetics, alginates, bile acid binders, reflux inhibitors, and antidepressants. Procedural options include laparoscopic fundoplication and LINX as well as endoscopic procedures, such as transoral incisionless fundoplication and Stretta. Several alternative and complementary treatments of possible benefit also exist. Keywords: PPI failure, resistant GERD, acid-related diseases, gastroesophageal reflux disease, acid reflux, proton pump inhibitors

Introduction:Nigeria has the largest burden of Sickle Cell Disease (SCD) with estimated 100,000 new born affected annually. SCD is a Hemoglobin (Hb) disorder with the major form resulting from the substitution of a polar glutamate (Glu) by non-polar Valine (Val) in an invariant region of Hbβ chain-subunit. Species of Hb found in the sickle cell trait are HbA and HbS in a 60:40 proportion, in SCD only HbS, in the HbC disease only HbC, and in the SC disease it's HbS and HbC in a 50:50 equal proportion.Objective:This paper reviews herbal medicines usage in sub-Saharan Africa (sSA) to ameliorate the crisis associated with SCD. The model Hb tetramer suggests a higher membrane affinity of HbS and HbC, promoting dehydration of RBCs, with concomitant in vivo crystallization. Some drawbacks using these herbal drugs include; poor bioavailability and the lack of proper pharmacovigilance monitoring procedures arising from weak governance structure combined with under reporting of herbal usage to physicians were discussed. Probable epigenetic loci that could be targeted using phytomedicines for effective SCD management were also discussed.Methods:Using search engines, several databases including Google scholar, PubMed, Academic Resource Index were utilized as a source for relevant publications/ literature. The protein coordinates for the Hb tetramer were obtained from the Protein Data Bank (PDB).Conclusion:Manipulation of epigenetics to achieve better SCD management involves careful thinking. Herein, we discuss some epigenetic interactions that could be putatively tweaked with a view of enhancing soluble bioactive small molecular components with the potential to reactivate γ -globin genes, thereby boosting immune response in patient with SCD.

Background Melphalan 200 mg/m2 (MEL 200) is standard conditioning for autologous transplant (auto-HCT) in multiple myeloma (MM). Melphalan 140 or 100 mg/m2 (MEL 140/100) is given to patients with advanced age or renal dysfunction. Prior comparisons of MEL 200 versus MEL 140/100 raised concerns about reduced efficacy with MEL 140/100. However, those studies took place prior to the era of induction and post-auto-HCT maintenance with novel agents. We asked whether a diverse, unselected MM cohort treated with novel agents maintains the full benefit of auto-HCT from MEL 140/100. Methods We reviewed 55 consecutive auto-HCT episodes for MM and amyloidosis patients treated with proteasome inhibitors (PI) and/or immunomodulators (IMiD) followed by MEL 200 (n = 30), MEL 140 (n = 20), and MEL 100 (n = 5) from 2006 to 2018. Patients with age > 70 or reduced renal function, Karnofsky score, or cardiopulmonary function received MEL 140/100. We analyzed pre-auto-HCT prognostic factors. We examined post-transplant toxicities and disease control. Statistical analyses were performed with SPSS25. Results Female and non-Caucasian patients were well-represented. Pre-transplant therapy was similar. MEL 140/100 trended towards older age and worse Karnofsky score; MEL 140/100 had significantly worse HCT-CI, ISS stage, and renal function (GFR Conclusion MM patients with higher ISS and HCT-CI scores tolerated auto-HCT with MEL 140/ 100 conditioning, Post-transplant outcomes were indistinguishable. Conditioning with MEL 140/100 has equivalent safety and efficacy for patients who are not candidates for MEL 200.